EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Mesenchymal Stromal Cells Mitigate Prolonged Cardiopulmonary Bypass-Induced Neuroinflammation

Kei Kobayashi iD, Takuya Maeda, Nemanja Saric, Kamil Sarkislali, Akihisa Furuta, Chase D McCann, Patrick J Hanley, David Zurakowski iD, Nobuyuki Ishibashi iD

Interdisciplinary CardioVascular and Thoracic Surgery · 06.11.2025 · 40 (11)

DOI: 10.1093/icvts/ivaf267 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Interdisciplinary CardioVascular and Thoracic Surgery, online erschienen am 06.11.2025. Verfasst von Kei Kobayashi und 8 weiteren Autor:innen. Beteiligte Einrichtung: Children's National Heart Center and Center for Neuroscience Research, Children's National Hospital, Washington, DC, 20010, United States. Hauptthemen laut MEDLINE: Cardiopulmonary Bypass, Mesenchymal Stem Cell Transplantation, Neuroinflammatory Diseases, Microglia. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NINDS NIH HHS, NHLBI NIH HHS, NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

Bone marrow-derived mesenchymal stromal cell (BM-MSC) delivery through cardiopulmonary bypass (CPB) can modulate CPB-induced systemic inflammation and inhibit microglial activation. The present study assessed whether BM-MSC treatment remains effective for extensive inflammatory reactions.

Methods

Two-week-old piglets were randomized into control, CPB with deep hypothermic circulatory arrest (DHCA), CPB with BM-MSCs, CPB with DHCA plus 180 min extended perfusion, and extended CPB with BM-MSCs. Human BM-MSCs (1 × 107 cells/kg) were delivered via the CPB circuit during rewarming. We measured 9 porcine plasma cytokines. Brains were harvested for microglial immunohistochemistry and premotor cortex RNA-sequencing.

Results

A total of 20 piglets were included (n = 4 per group). An extended CPB period increased the number of white matter microglia and plasma interferon-g (IFN-g) and TNF-a levels compared to standard CPB (P < .05). Notably, BM-MSCs normalized the extensive microglia expansion resulting from prolonged CPB (P < .001). In addition to reduced IFN-g and increased IL-10, BM-MSCs increased IL-1b and IL-8 levels, suggesting possible immunosuppressive reactions observed under inflammatory microenvironment. Gene ontology analyses in the premotor cortex post-CPB found involvement of NF-kB signalling. While there was a positive correlation between IFN-g and microglia expansion/activation, IL-10 levels were inversely correlated with the number of microglia. Consistent with immunosuppressive roles in the inflammatory environment, we found inverse correlations between IL-1b and IL-8 levels and CPB-induced microglial activation (P < .01).

Conclusions

BM-MSC administration via CPB shows promise for reducing extensive inflammatory stress. Further investigation using this model will elucidate CPB-induced unique pathological events in the developing brain and mechanisms underlying the therapeutic actions of BM-MSC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cardiopulmonary BypassMesenchymal Stem Cell TransplantationNeuroinflammatory DiseasesMicrogliaAnimalsCytokinesSwineDisease Models, AnimalMesenchymal Stem CellsHumansTime FactorsInflammation MediatorsMotor Cortex

Stichwörter der Autor:innen

cardiopulmonary bypasscytokinesinflammationmesenchymal stem cellsmicroglia

Substanzen

CytokinesInflammation Mediators

Autor:innen und Institutionen

  • Children's National Heart Center and Center for Neuroscience Research, Children's National Hospital, Washington, DC, 20010, United States.
  • Program for Cell Enhancement and Technologies for Immunotherapy, Division of Blood and Marrow Transplantation, Center for Cancer and Immunology Research, Children's National Hospital, Washington, DC, 20010, United State…
  • George Washington University School of Medicine and Health Science, Washington, DC, 20037, United States.
  • Department of Anesthesiology, Boston Children's Hospital, Harvard Medical School, Boston, MA, 02115, United States.
  • Department of Surgery, Boston Children's Hospital, Harvard Medical School, Boston, MA, 02115, United States.

ORCID-Profile: Kei Kobayashi, David Zurakowski, Nobuyuki Ishibashi

Förderung

  • NINDS NIH HHS
  • NHLBI NIH HHS
  • NIH HHS
  • National Institutes of Health

Zitieren

APA

Kobayashi, K., Maeda, T., Saric, N., Sarkislali, K., Furuta, A., McCann, C. D., Hanley, P. J., Zurakowski, D., & Ishibashi, N. (2025). Mesenchymal Stromal Cells Mitigate Prolonged Cardiopulmonary Bypass-Induced Neuroinflammation. Interdisciplinary CardioVascular and Thoracic Surgery, 40(11). https://doi.org/10.1093/icvts/ivaf267

Vancouver

Kobayashi K, Maeda T, Saric N, Sarkislali K, Furuta A, McCann CD, et al. Mesenchymal Stromal Cells Mitigate Prolonged Cardiopulmonary Bypass-Induced Neuroinflammation. Interdisciplinary CardioVascular and Thoracic Surgery. 2025;40(11). doi:10.1093/icvts/ivaf267

BibTeX
@article{Kobayashi2025,
  author = {Kobayashi, Kei and Maeda, Takuya and Saric, Nemanja and Sarkislali, Kamil and Furuta, Akihisa and McCann, Chase D and Hanley, Patrick J and Zurakowski, David and Ishibashi, Nobuyuki},
  title = {Mesenchymal Stromal Cells Mitigate Prolonged Cardiopulmonary Bypass-Induced Neuroinflammation},
  journal = {Interdisciplinary CardioVascular and Thoracic Surgery},
  year = {2025},
  volume = {40},
  number = {11},
  doi = {10.1093/icvts/ivaf267}
}
Kostenlos starten →